Sun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs Expected

From the company, senior vice president Rahul Awasthi and associate vice president Ranjit Mohapatra met Kota.

"The proposal involves establishing drug formulation manufacturing units in the state to cater to the Indian market, with a planned investment of over Rs 500 crore to be implemented in two phases," the chief secretary said.

The project is expected to generate direct employment for more than 500 people in a phased manner after commencement of operations, he added.

"Key aspects such as land requirements, availability of water and power, connectivity, and access to skilled manpower were discussed," Kota said.

The company also outlined its focus on sustainable manufacturing practices, including efficient water use, increased adoption of renewable energy and responsible waste management, in line with environmental and regulatory standards, he added.

The meeting was part of the Assam government's ongoing engagement with prospective investors to promote employment generation, inclusive development, and long-term economic growth in the state," Kota added.

Sun Pharmaceutical is the world's fourth-largest and India's largest pharmaceutical company with over 40 manufacturing facilities across five continents and operations in more than 100 countries, he added.